OTCMKTS:TMED

Trimedyne (TMED) Stock Price, News & Analysis

$4.25
-0.01 (-0.23%)
(As of 03/20/2020)
Today's Range
$4.25
$4.25
50-Day Range
$4.25
$4.25
52-Week Range
$3.48
$7.00
Volume
100 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TMED stock logo

About Trimedyne Stock (OTCMKTS:TMED)

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

TMED Stock Price History

TMED Stock News Headlines

See More Headlines
Receive TMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2018
Today
5/19/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:TMED
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Glenn D. Yeik (Age 51)
    Interim Chairman, CEO & Pres
  • Mr. Brian T. Kenney (Age 62)
    VP of Global Sales & Marketing

TMED Stock Analysis - Frequently Asked Questions

How have TMED shares performed in 2024?

Trimedyne's stock was trading at $4.25 at the start of the year. Since then, TMED shares have increased by 0.0% and is now trading at $4.25.
View the best growth stocks for 2024 here
.

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) posted its quarterly earnings results on Tuesday, February, 20th. The technology company reported $0.70 earnings per share for the quarter. The technology company had revenue of $1.53 million for the quarter.

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL), Diana Shipping (DSX), Cohen & Steers Closed-End Opportunity Fund (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), The Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK).

How do I buy shares of Trimedyne?

Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TMED) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners